Insider

Dexcom Inc

DXCM Health Care · No analyses yet

Mentioned in recent filings: Tariffs

What changed

No articles about this company yet. Follow it to hear when the first one appears.

Sector peers

How this company compares with 36 covered companies in Health Care (median revenue change +7.2% YoY), from archived SEC XBRL filings.

CompanyLatest revenueRevenue YoYOperating margin
Dexcom Inc DXCM———
Unitedhealth Group Inc UNH$113B-0.4%5.8%
Mckesson Corp MCK$111B+7.6%1.4%
CVS Health Corp CVS$108B+5.4%3.3%
Cigna Group CI$73.7B+5.6%3.3%
Cardinal Health Inc CAH$67.5B+5.5%1.1%
Elevance Health, Inc. ELV$51.4B+1.4%2.5%

Latest reported period per company from SEC CompanyFacts (XBRL). Fiscal calendars differ across companies.

Governance events

Filings about how the company is run: auditor changes, restatements, leadership changes, late filings, delistings, Schedule 13D stakes and SEC comment letters, newest first.

DateEventFiling
September 14, 2026Director or officer departure or appointment (8-K item 5.02)8-K

As filed with the SEC, read by code. A comment letter is part of the SEC staff’s routine review and does not by itself mean a problem; item 5.02 covers appointments as well as departures; Form 25 may concern a bond or another class of securities.

Large funds (13F)

FundSharesValueChange in sharesQuarter
BlackRock38,244,137$2,575,742,626-1.8%Q2 2026
State Street18,380,806$1,237,947,284+2.5%Q2 2026
Geode Capital Management12,426,515$834,165,910+0.6%Q2 2026
Wellington Management8,527,471$574,325,172-8.6%Q2 2026
Norges Bank (Norway's sovereign fund)6,868,090$462,565,862—Q2 2026
Fidelity (FMR)1,893,246$127,510,091+13.2%Q2 2026
Renaissance Technologies1,630,796$109,834,111+3.0%Q2 2026
Citadel Advisors1,211,767$81,612,507-42.1%Q2 2026
Bridgewater Associates400,929$27,002,568+187.0%Q2 2026
Millennium Management395,392$26,629,651-75.6%Q2 2026
Two Sigma Investments46,697$3,145,043-95.8%Q2 2026
D. E. Shaw & Co.5,679$382,481-79.5%Q2 2026
T. Rowe Price2,238,713$150,778+54.9%Q2 2026

From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.